Importer of Controlled Substances; Notice of Registration, 17471 [05-6797]

Download as PDF Federal Register / Vol. 70, No. 65 / Wednesday, April 6, 2005 / Notices 17471 and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Schedule the public interest at this time. DEA has investigated Aldrich Chemical Company, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: March 29, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–6794 Filed 4–5–05; 8:45 am] DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By notice dated December 21, 2004 and published in the Federal Register on January 4, 2005 (70 FR 389), Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substances listed in Schedule II. The company plans to import the phenylacetone to manufacture amphetamine for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Cambrex Charles City, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cambrex Charles City, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) 18:17 Apr 05, 2005 Jkt 205001 BILLING CODE 4410–09–M DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; Correction BILLING CODE 4410–09–P VerDate jul<14>2003 Dated: March 29, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–6797 Filed 4–5–05; 8:45 am] By Notice dated December 21, 2004, and published in the Federal Register on January 4, 2005, (70 FR 390), the listing of controlled substances N– Ethylamphetamine (1475), 2,5– Dimethoxyamphetamine (7396), 4– Methoxyamphetamine (7411), and Difenoxin (9168), were inadvertently added for Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409. The Notice of Application should be corrected by deleting N– Ethylamphetamine (1475), 2,5– Dimethoxyamphetamine (7396), 4– Methoxyamphetamine (7411), and Difenoxin (9168). Dated: March 29, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–6788 Filed 4–5–05; 8:45 am] BILLING CODE 4410–09–P Drug 2,5–Dimethoxyamphetamine (7396). 4–Methoxyamphetamine (7411) ... Difenoxin (9168) ........................... Methamphetamine (1105) ............ Raw Opium (9600) ....................... Concentrate of Poppy Straw (9670). I I I II II II The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. Sections 823(a) and 952(a) and determined that the registration of Cambrex Charles City, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cambrex Charles City, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. Sections 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: March 29, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–6795 Filed 4–5–05; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration DEPARTMENT OF JUSTICE Importer of Controlled Substances; Notice of Registration Drug Enforcement Administration By Notice dated December 21, 2004 and published in the Federal Register on January 4, 2005, (70 FR 390), Chattem Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in Schedule I and II: Drug Schedule N–Ethylamphetamine (1475) ........ PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 I Manufacturer of Controlled Substances; Notice of Application; Correction By notice dated July 21, 2004, and published in the Federal Register on August 10, 2004 (69 FR 48522), Dade Behring Inc., Route 896 Corporate Boulevard, Building 100, Attention: RA/ QA, Post Office Box 6101, Newark, Delaware 19717 made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer, and to modify its address. The address modification was inadvertently omitted. The state of E:\FR\FM\06APN1.SGM 06APN1

Agencies

[Federal Register Volume 70, Number 65 (Wednesday, April 6, 2005)]
[Notices]
[Page 17471]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6797]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By notice dated December 21, 2004 and published in the Federal 
Register on January 4, 2005 (70 FR 389), Cambrex Charles City, Inc., 
1205 11th Street, Charles City, Iowa 50616, made application by renewal 
to the Drug Enforcement Administration (DEA) to be registered as an 
importer of Phenylacetone (8501), a basic class of controlled 
substances listed in Schedule II.
    The company plans to import the phenylacetone to manufacture 
amphetamine for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Cambrex Charles City, Inc. to import the basic classes 
of controlled substances is consistent with the public interest and 
with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971, at this time. DEA 
has investigated Cambrex Charles City, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic class of controlled substance 
listed.

    Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-6797 Filed 4-5-05; 8:45 am]
BILLING CODE 4410-09-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.